Some reactions and properties of nitro radical-anions important in biology and medicine.
Nitroaromatic compounds, ArNO2 have widespread actual or potential use in medicine and cancer therapy. There is direct proof that free-radical metabolites are involved in many applications, and an appreciation of the conceptual basis for their therapeutic differential; however, an understanding of the detailed mechanisms involved is lacking. Redox properties control most biological responses of nitro compounds, and the characteristics of the one-electron couple: ArNO2/ArNO2- are detailed. The "futile metabolism" of nitroaryl compounds characteristic of most aerobic nitroreductase systems reflects competition between natural radical-decay pathways and a one-electron transfer reaction to yield superoxide ion, O2-. Prototropic properties control the rate of radical decay, and redox properties control the rate of electron transfer to O2 or other acceptors. There are clear parallels in the chemistry of ArNO2- and O2-. While nitro radicals have frequently been invoked as damaging species, they are very unreactive (except as simple reductants). It seems likely that reductive metabolism of nitroaryl compounds, although generally involving nitro radical-anions as obligate intermediates (and this is required for therapeutic selectivity towards anaerobes), results in biological damage via reductive metabolites of higher reduction order than the one-electron product.
D000970:Antineoplastic Agents; D055598:Chemical Phenomena; D002621:Chemistry; D004579:Electron Transport; D005609:Free Radicals; D006801:Humans; D007700:Kinetics; D009369:Neoplasms / Q000188:drug therapy; D009574:Nitro Compounds / Q000627:therapeutic use; D010084:Oxidation-Reduction; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D005609:Free Radicals; D009574:Nitro Compounds